Protein kinase CK2 and protein kinase D are associated with the COP9 signalosome

被引:162
|
作者
Uhle, S
Medalia, O
Waldron, R
Dumdey, R
Henklein, P
Bech-Otschir, D
Huang, X
Berse, M
Sperling, J
Schade, R
Dubiel, W
机构
[1] Humboldt Univ, Fac Med Charite, Dept Surg, Div Mol Biol,Inst Biochem, D-10117 Berlin, Germany
[2] Humboldt Univ, Fac Med Charite, Dept Surg, Div Mol Biol,Inst Pharmacol & Toxicol, D-10117 Berlin, Germany
[3] Max Planck Inst Biochem, Dept Biol Struct, D-82152 Martinsried, Germany
[4] Univ Calif Los Angeles, Sch Med, Dept Med, Div Digest Dis, Los Angeles, CA 90095 USA
[5] Weizmann Inst Sci, Dept Chem, IL-76100 Rehovot, Israel
来源
EMBO JOURNAL | 2003年 / 22卷 / 06期
关键词
c-Jun; COP9; signalosome; protein kinase CK2; protein kinase D; p53;
D O I
10.1093/emboj/cdg127
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The COP9 signalosome (CSN) purified from human erythrocytes possesses kinase activity that phosphoryl ates proteins such as c-Jun and p53 with consequence for their ubiquitin (Ub)-dependent degradation. Here we show that protein kinase CK2 (CK2) and protein kinase D (PKD) co-purify with CSN. Immunoprecipi tation and far-western blots reveal that CK2 and PKD are in fact associated with CSN. As indicated by electron microscopy with gold-labeled ATP, at least 10% of CSN particles are associated with kinases. Kinase activity, most likely due to CK2 and PKD, co-immuno precipitates with CSN from HeLa cells. CK2 binds to DeltaCSN3(111-403) and CSN7, whereas PKD interacts with full-length CSN3. CK2 phosphorylates CSN2 and CSN7, and PKD modifies CSN7. Both CK2 and PKD phosphorylate c-Jun as well as p53. CK2 phosphoryl ates Thr155, which targets p53 to degradation by the Ub system. Curcumin, emodin, DRB and resveratrol block CSN-associated kinases and induce degradation of c-Jun in HeLa cells. Curcumin treatment results in elevated amounts of c-Jun-Ub conjugates. We conclude that CK2 and PKD are recruited by CSN in order to regulate Ub conjugate formation.
引用
收藏
页码:1302 / 1312
页数:11
相关论文
共 50 条
  • [21] Protein kinase CK2 in human diseases
    Guerra, Barbara
    Issinger, Olaf-Georg
    CURRENT MEDICINAL CHEMISTRY, 2008, 15 (19) : 1870 - 1886
  • [22] Protein kinase CK2 and cell polarity
    Alexandre Deshière
    Nathalie Theis-Febvre
    Véronique Martel
    Claude Cochet
    Odile Filhol
    Molecular and Cellular Biochemistry, 2008, 316 : 107 - 113
  • [23] Protein kinase CK2 as a druggable target
    Sarno, Stefania
    Pinna, Lorenzo A.
    MOLECULAR BIOSYSTEMS, 2008, 4 (09) : 889 - 894
  • [24] Protein kinase CK2 and cell polarity
    Deshiere, Alexandre
    Theis-Febvre, Nathalie
    Martel, Veronique
    Cochet, Claude
    Filhol, Odile
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2008, 316 (1-2) : 107 - 113
  • [25] Protein kinase CK2: a challenge to canons
    Pinna, LA
    JOURNAL OF CELL SCIENCE, 2002, 115 (20) : 3873 - 3878
  • [26] CK2, a protein kinase of the next millennium
    Dobrowolska, G
    Lozeman, FJ
    Li, DX
    Krebs, EG
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 1999, 191 (1-2) : 3 - 12
  • [27] Protein Kinase CK2 in Cancer Energetics
    Silva-Pavez, Eduardo
    Tapia, Julio C.
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [28] Interactions of protein kinase CK2 subunits
    Iris Korn
    Silvio Gutkind
    N. Srinivasan
    Tom L. Blundell
    Catherine C. Allende
    Jorge E. Allende
    Molecular and Cellular Biochemistry, 1999, 191 : 75 - 83
  • [29] CK2, a protein kinase of the next millennium
    Grazyna Dobrowolska
    Fred J. Lozeman
    Dongxia Li
    Edwin G. Krebs
    Molecular and Cellular Biochemistry, 1999, 191 : 3 - 12
  • [30] Regulation of protein kinase CK2 catalytic activity by protein kinase C and phospholipase D2
    Lee, Young-Hoon
    Park, Jeong-Woo
    Bae, Young-Seuk
    BIOCHIMIE, 2016, 121 : 131 - 139